378 related articles for article (PubMed ID: 12107240)
21. Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways.
Chen SU; Chou CH; Lin CW; Lee H; Wu JC; Lu HF; Chen CD; Yang YS
Hum Reprod; 2010 Mar; 25(3):757-67. PubMed ID: 20008399
[TBL] [Abstract][Full Text] [Related]
22. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.
Pellicer A; Albert C; Mercader A; Bonilla-Musoles F; Remohí J; Simón C
Fertil Steril; 1999 Mar; 71(3):482-9. PubMed ID: 10065786
[TBL] [Abstract][Full Text] [Related]
23. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome.
Agrawal R; Tan SL; Wild S; Sladkevicius P; Engmann L; Payne N; Bekir J; Campbell S; Conway G; Jacobs H
Fertil Steril; 1999 Feb; 71(2):287-93. PubMed ID: 9988400
[TBL] [Abstract][Full Text] [Related]
24. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
Tozer AJ; Iles RK; Iammarrone E; Gillott CM; Al-Shawaf T; Grudzinskas JG
Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
[TBL] [Abstract][Full Text] [Related]
25. Plasma levels of free vascular endothelial growth factor(165) (VEGF(165)) are not elevated during gonadotropin stimulation in in vitro fertilization (IVF) patients developing ovarian hyperstimulation syndrome (OHSS): results of a prospective cohort study with matched controls.
Enskog A; Nilsson L; Brännström M
Eur J Obstet Gynecol Reprod Biol; 2001 Jun; 96(2):196-201. PubMed ID: 11384807
[TBL] [Abstract][Full Text] [Related]
26. Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSS-like symptoms in rhesus monkeys.
Bishop CV; Lee DM; Slayden OD; Li X
J Ovarian Res; 2017 Jul; 10(1):41. PubMed ID: 28683759
[TBL] [Abstract][Full Text] [Related]
27. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of AREG, EGFR, and HER2 contributes to increased VEGF expression in granulosa cells of patients with OHSS†.
Fang L; Yu Y; Li Y; Wang S; He J; Zhang R; Sun YP
Biol Reprod; 2019 Aug; 101(2):426-432. PubMed ID: 31167229
[TBL] [Abstract][Full Text] [Related]
29. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.
Agrawal R; Conway G; Sladkevicius P; Tan SL; Engmann L; Payne N; Bekir J; Campbell S; Jacobs H
Fertil Steril; 1998 Oct; 70(4):651-8. PubMed ID: 9797093
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factors-1 and -2, but not hypoxia, synergize with gonadotropin hormone to promote vascular endothelial growth factor-A secretion by monkey granulosa cells from preovulatory follicles.
Martinez-Chequer JC; Stouffer RL; Hazzard TM; Patton PE; Molskness TA
Biol Reprod; 2003 Apr; 68(4):1112-8. PubMed ID: 12606472
[TBL] [Abstract][Full Text] [Related]
31. sRAGE downregulates the VEGF expression in OHSS ovarian granulosa cells.
Wang B; Wang J; Liu Y; Wang L; Du M; Zhang Z; Guan Y
Gynecol Endocrinol; 2021 Sep; 37(9):836-840. PubMed ID: 34223781
[TBL] [Abstract][Full Text] [Related]
32. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome.
Kobayashi H; Okada Y; Asahina T; Gotoh J; Terao T
J Mol Endocrinol; 1998 Jun; 20(3):363-74. PubMed ID: 9687159
[TBL] [Abstract][Full Text] [Related]
33. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent.
Neulen J; Raczek S; Pogorzelski M; Grunwald K; Yeo TK; Dvorak HF; Weich HA; Breckwoldt M
Mol Hum Reprod; 1998 Mar; 4(3):203-6. PubMed ID: 9570265
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.
Abramov Y; Barak V; Nisman B; Schenker JG
Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600
[TBL] [Abstract][Full Text] [Related]
35. Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles.
Christenson LK; Stouffer RL
J Clin Endocrinol Metab; 1997 Jul; 82(7):2135-42. PubMed ID: 9215284
[TBL] [Abstract][Full Text] [Related]
36. Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome.
Tong XM; Zhang SY; Song T; Xu WH; Lin XN; Shu J; Liu L
Chin Med J (Engl); 2008 Dec; 121(23):2434-9. PubMed ID: 19102964
[TBL] [Abstract][Full Text] [Related]
37. Higher melatonin in the follicle fluid and MT2 expression in the granulosa cells contribute to the OHSS occurrence.
Li Y; Fang L; Yu Y; Shi H; Wang S; Guo Y; Sun Y
Reprod Biol Endocrinol; 2019 Apr; 17(1):37. PubMed ID: 30979376
[TBL] [Abstract][Full Text] [Related]
38. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
[TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial cadherin regulates vascular permeability: Implications for ovarian hyperstimulation syndrome.
Villasante A; Pacheco A; Ruiz A; Pellicer A; Garcia-Velasco JA
J Clin Endocrinol Metab; 2007 Jan; 92(1):314-21. PubMed ID: 17032719
[TBL] [Abstract][Full Text] [Related]
40. The role of pigment epithelium-derived factor in the pathophysiology and treatment of ovarian hyperstimulation syndrome in mice.
Chuderland D; Ben-Ami I; Kaplan-Kraicer R; Grossman H; Ron-El R; Shalgi R
J Clin Endocrinol Metab; 2013 Feb; 98(2):E258-66. PubMed ID: 23295464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
